These studies address fundamental and unexplored questions: (1) Is neuronal PITRM1, in particular proteolytic activity, sufficient to constantly degrade and clear mitochondrial Aβ in the late stage of the AD mouse model even with extensive amyloid pathology and mitochondrial dysfunction? This evidence concerns the gene PITRM1 and amyloidosis.